Natural Health Products Regulations, SOR/2003-196
Section 79
Cite as Natural Health Products Regulations, SOR/2003-196, s. 79 · current to October 14, 2025 · regulation last amended June 21, 2025
Statute Watch
Get an alert when a bill in Parliament would change this section, and every time it moves.
The text
(1) If the sponsor discontinues a clinical trial in its entirety or at a clinical trial site, the sponsor shall
(a) notify the Minister of the discontinuance within 15 days after the day of the discontinuance;
(b) provide the Minister with the reason for the discontinuance and its impact on the proposed or ongoing clinical trials in respect of the natural health product conducted in Canada by the sponsor;
(c) as soon as possible, notify all qualified investigators of the discontinuance and of the reasons for the discontinuance, and advise them in writing of any potential risks to the health of clinical trial subjects or other persons; and
(d) in respect of each discontinued clinical trial site, stop the sale or importation of the natural health product as of the day of the discontinuance and take all reasonable measures to ensure the recovery of all unused quantities of the natural health product that have been sold.
(2) If the sponsor discontinues a clinical trial in its entirety or at a clinical trial site, the sponsor may resume selling or importing the natural health product for the purposes of the clinical trial in its entirety or at the clinical trial site if, in respect of each clinical trial site where the sale or importation is to be resumed, the sponsor submits to the Minister the information referred to in subparagraphs 66(c)(ix) to (xi) and paragraphs 66(d) and (f).
Read the Natural Health Products Regulations on the Justice Laws Website ↗
Made under Food and Drugs Act, R.S.C. 1985, c. F-27.
Bills in Parliament that would change this section 0
No bill we hold would amend or repeal this section.